ACE Inhibitors: the Cough, the Potassium and Pregnancy

One mechanism, three consequences, and one of those consequences is a hard stop rather than a caution. ACE inhibitors are the cleanest example of reading a drug's whole profile off what it does.

The mechanism, stated plainly

StatPearls describes ACE inhibitors as blocking the conversion of angiotensin I to angiotensin II. Two things follow immediately from that: less vasoconstriction, and less aldosterone release.

Blood pressure falls because vessels stop being told to constrict. That half is the point of the prescription.

The aldosterone half is where the side effects live. Aldosterone drives potassium excretion, so blocking it means less potassium leaves the body than before.

Why the class gets prescribed at all

None of these consequences would be tolerated if the drug were not doing something worth having. Reducing vasoconstriction and reducing aldosterone release lowers pressure and lightens the load on a heart that is struggling to keep up.

That is worth saying to a patient weighing a cough against a benefit they cannot feel. Blood pressure treatment is almost entirely invisible to the person taking it.

It is also worth saying to yourself before an item. A drug's purpose is part of the reasoning rather than background detail, and options that stop a drug without a reason are usually wrong for exactly that reason.

The cough, and where it comes from

The dry cough is what patients actually complain about, and StatPearls puts it at 10 to 20%. The mechanism is bradykinin accumulation rather than anything happening in the lungs themselves, which is why treating it as a respiratory problem goes nowhere.

The source also notes that it resolves after the drug is discontinued. That one detail answers a lot of items, because the correct response to a persistent dry cough on an ACE inhibitor is neither a cough suppressant nor reassurance that it will settle down eventually.

Patients stop taking these drugs over this. A cough that keeps someone awake is a genuine adherence problem, and treating it as trivial is how a blood pressure regimen quietly falls apart.

The potassium

Hyperkalemia is reported at 2 to 6% in the same source, and the reason is the aldosterone step rather than anything mysterious happening downstream.

The practical consequence is about combinations. A patient on an ACE inhibitor who also takes a potassium supplement, or a potassium-sparing diuretic, or a salt substitute made with potassium chloride, is stacking one effect from several directions at once.

What a shifting potassium does to the ECG has its own post, and it is worth reading before any rhythm-heavy practice set.

Pregnancy is not a caution

This is the entry that gets softened in study material, and it should not be. StatPearls lists ACE inhibitor use in pregnancy as an absolute contraindication.

The named fetal effects are oligohydramnios, decreased fetal renal function, anuria, renal failure, skull hypoplasia, and death. The risk is described particularly for the second and third trimesters, with documented first-trimester risk as well.

Read the phrase absolute contraindication exactly as written. Not relative. Not weigh the risks.

In a stem, that means any option involving continuing the drug, reassuring the patient, or waiting until the next appointment is wrong on its face.

What to teach the patient

Two instructions carry most of the risk here. Report a persistent dry cough instead of living with it, and check before adding anything containing potassium, including salt substitutes.

Position changes matter as well, since blood pressure is being lowered on purpose. Stand up slowly, especially in the first days and after any dose increase.

And raise the pregnancy point early with anyone who could become pregnant, rather than waiting for it to come up on its own. That conversation is easier before it is urgent.

Angioedema, and why it is on every list

Angioedema is rare and serious, and it can require airway management. The same source says to avoid these drugs in anyone with hereditary angioedema or a previous angioedema episode of any cause.

Rare plus airway is the combination that gets a fact onto every exam. Frequency does not decide priority. Consequence does.

How these items are usually built

The stem hands you a patient on an ACE inhibitor plus one new detail. A cough, a potassium result, a positive pregnancy test, or a swollen lip.

Each of those points at a different action and the actions are not interchangeable. A cough gets reported. A potassium gets read against the whole medication list. A pregnancy stops the drug. A swollen lip is an airway problem until proven otherwise.

Sorting by consequence rather than by how common something is gets these items right. The rare one outranks the frequent one whenever an airway is involved.

The related class worth naming

ACE inhibitors and ARBs appear together on StatPearls' list of drug classes that raise lithium levels, which is a useful reminder that the two share a route of action.

That overlap is why a patient on lithium starting either one needs the interaction checked rather than assumed, and it is covered properly here.

Monitoring, which you could have predicted

StatPearls lists creatinine, BUN, potassium, blood pressure, and occasionally a CBC.

Put that list beside the mechanism and nothing on it is a surprise. A drug acting on the renin-angiotensin system gets monitored on renal markers, on the electrolyte it moves, and on the pressure it was prescribed to change.

That derivation is the whole method described in the mechanism-first pillar post.

How ACE inhibitors sit against the other cardiovascular classes is a separate comparison. Selectivity is the deciding axis for beta blockers, and the workload-reducing classes are laid out together in the calcium channel blocker and nitrate post.

The two things people get backwards

The first is treating the cough as a respiratory problem. It is a bradykinin problem, and it does not respond to the things a respiratory problem responds to.

The second is filing the pregnancy entry alongside the other cautions. It does not belong there. An absolute contraindication and a common side effect are different categories of fact and they call for different actions.

Separate those two and most ACE inhibitor items stop being difficult.

Three consequences. One mechanism. That is the whole class.